Form 4 for NBIX NEUROCRINE BIOSCIENCES INC
Accepted 2025-12-02 00:00:00 ET · period of report 2025-11-29 · accession 0001894425-25-000010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-02 | 2025-11-29 | NBIX | Onyia Jude | CSO | F - Tax | $152.16 | -2,248 | 15.9K | -12% | -$342.1K |
| D | 2025-12-02 | 2025-11-29 | NBIX | Onyia Jude | CSO | M - OptEx | $0.00 | +4,426 | 18.1K | +32% | $0 |
| D | 2025-12-02 | 2025-11-29 | NBIX | Onyia Jude | CSO | M - OptEx | $0.00 | -4,426 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-29 | F | D | 2,248 | $152.16 | 15,881 | D | — | — | (F1) Shares withheld by Neurocrine Biosciences, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. |
| 2 | Common | Common Stock | 2025-11-29 | M | A | 4,426 | $0.00 | 18,129 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2025-11-29 | M | D | 4,426 | $0.00 | 0 | D | — · — to — | 4,426 Common Stock | (F2) Each Restricted Stock Unit represents a contingent right to receive one share of the Neurocrine Common Stock. (F3) This RSU was granted to the Reporting Person on November 29, 2021. In accordance with the terms of the RSU, the award vested as to 4,425 shares on November 29, 2022, vested as to 4,425 shares on November 29, 2023, vested as to 4,426 shares on November 29, 2024, and vested as to 4,426 shares on November 29, 2025, subject to the terms and conditions of the award. |